Intelligence Hub
Market analytics and operational performance indicators
144 - March 5, 2024
Officer Arjun Kampani to sell 31,394 vested RKLB shares worth $133K.
Brief
Form 144 discloses Rocket Lab officer Arjun Kampani's intent to sell 31,394 common shares acquired via restricted stock vesting on 03/01/2024 as compensation. Aggregate market value is $133,515.54, with proposed sale around 03/05/2024 via Fidelity on NASDAQ. Relevant to investors as routine insider sale with no prior 3-month activity and certification of no undisclosed material adverse information.
Detailed Brief
Form 144 is a notice of proposed sale of restricted securities under Rule 144 by affiliates of the issuer. Here, Arjun Kampani, an officer of Rocket Lab USA, Inc., reports intent to sell 31,394 common shares recently vested from restricted stock units on March 1, 2024, received as compensation from the issuer. The shares represent a tiny fraction (about 0.006%) of the 489,140,411 outstanding shares, valued at $133,515.54 based on market price. No securities were sold by Kampani in the past 3 months, and the filing includes a representation of no known material adverse information. This is standard practice for executives monetizing vested equity compensation amid Rocket Lab's growth in launch services and space systems.
Key Telemetry
- • Arjun Kampani (Officer) to sell 31,394 common shares on ~03/05/2024.
- • Shares vested 03/01/2024 from RSUs as compensation; value $133,515.54.
- • 31,394 shares vs. 489M outstanding; broker Fidelity.
- • No sales in past 3 months; no material adverse info disclosed.
Impact Vector
Negligible near-term impact for RKLB investors; sale is minor (0.006% of shares) routine monetization of vested comp by officer, with clean disclosure and no recent selling pattern. Strategically neutral, as executives often sell vested RSUs for liquidity/diversification. Monitor future Form 144s or 4s for insider selling trends amid Rocket Lab's operational milestones like Neutron development.